Abu Dhabi - Phase III trials of Russian Vaccine begin in Abu Dhabi. Sputnik V is a Russian human adenovirus-based vaccine. The trials are open to 500 volunteers where the participants will receive two doses of the vaccine, which will be administered 20 days apart, at a hospital in Abu Dhabi. Those interested can register on www.v4v.ae. Sputnik V was first approved in August 2020 by Russian Ministry of Health. Its efficacy is reported as 91.4%. The researchers developed their vaccine from adenovirusesa kind of virus that causes colds